DePuy Synthes Aims to Improve Operations with Ortho Restructure

Alongside its third-quarter earnings report, Johnson & Johnson announced a two-year restructuring of its orthopedics business. The move aims to simplify and focus operations so the company can better meet demand. DePuy Synthes will exit certain product lines and markets. All told, the restructuring will incur a modest $250 million revenue...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us